Evidence map›Paper›PMID 29799788›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2018

Ursolic acid facilitates apoptosis in rheumatoid arthritis synovial fibroblasts by inducing SP1-mediated Noxa expression and proteasomal degradation of Mcl-1.

Eugene Y Kim, Kuladeep Sudini, Anil K Singh, Mahamudul Haque, Douglas Leaman, Sadik Khuder, Salahuddin Ahmed

Abstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Effects and molecular mechanisms ofFrontiers in pharmacology · 2025
    Review
  3. Article
  4. Research in pharmaceutical sciences · 2022
    Article
  5. Review
  6. Anti-rheumatoid activity of a hexane-insoluble fraction fromJournal of traditional and complementary medicine · 2022
    Article
  7. Review
  8. Article
  9. A dual effect of ursolic acid to the treatment of multiple sclerosis through both immunomodulation and direct remyelination.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  10. Chemical Composition ofFrontiers in pharmacology · 2020
    Article
  11. Critical role of IL-1α in IL-1β-induced inflammatory responses: cooperation with NF-κBp65 in transcriptional regulation.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Eugene Y KimDepartment of Pharmaceutical Sciences, College of Pharmacy, Washington State University, Spokane, Washington, USA.
Kuladeep SudiniDepartment of Pharmacology, University of Toledo, Toledo, Ohio, USA.
Anil K SinghDepartment of Pharmaceutical Sciences, College of Pharmacy, Washington State University, Spokane, Washington, USA.
Mahamudul HaqueDepartment of Pharmaceutical Sciences, College of Pharmacy, Washington State University, Spokane, Washington, USA.
Douglas LeamanDepartment of Pharmacology, University of Toledo, Toledo, Ohio, USA.
Sadik KhuderDepartment of Medicine and Public Health, University of Toledo, Toledo, Ohio, USA.
Salahuddin AhmedDepartment of Pharmaceutical Sciences, College of Pharmacy, Washington State University, Spokane, Washington, USA.
University of Toledo · USWashington State University Spokane · USUniversity of Washington · US

Funding

Novel Targeted Therapeutics for Regulating Synovial Hyperplasia in RAR21AR068517 · NIAMS · WASHINGTON STATE UNIVERSITY · PI AHMED, SALAH-UDDIN · 2016 to 2017
$369k
NIAMS NIH HHS R21 AR068517
6 · The paper itself

Abstract

Rheumatoid arthritis (RA) is characterized by hyperplastic pannus formation mediated by activated synovial fibroblasts (RASFs) that cause joint destruction. We have shown earlier that RASFs exhibit resistance to apoptosis, primarily as a result of enhanced expression of myeloid cell leukemia-1 (Mcl-1). In this study, we discovered that ursolic acid (UA), a plant-derived pentacyclic triterpenoid, selectively induces B-cell lymphoma 2 homology 3-only protein Noxa in human RASFs. We observed that UA-induced Noxa expression was followed by a consequent decrease in Mcl-1 expression in a dose-dependent manner. Subsequent evaluation of the signaling pathways showed that UA-induced Noxa is primarily mediated by the JNK pathway in human RASFs. Chromatin immunoprecipitation (IP) studies into the promoter region of Noxa indicated the role of transcription factor specificity protein 1 in JNK-mediated Noxa expression. Furthermore, the results from IP studies and proximity ligation assays indicated that UA-induced Noxa colocalizes and associates with Mcl-1 to prime it for proteasomal degradation through K

Indexed as

BH3-only proteinsynovial hyperplasiaubiquitinationursolic acid

Identifiers

PMID29799788
PMCPMC6181629
OpenAlexW2804588987

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.